Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 2Thoracic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Melanoma 3Breast Neoplasms 2Uterine Cervical Neoplasms 1Smoking Cessation 1Prostatic Neoplasms 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 24Nivolumab 13atezolizumab 7Ipilimumab 6Cyclophosphamide 6fludarabine 5Specimen Handling 5Magnetic Resonance Spectroscopy 5aldesleukin 4Interleukin-2 4Biopsy 4durvalumab 3cemiplimab 3Docetaxel 3tislelizumab 2osimertinib 2fludarabine phosphate 2enzalutamide 2avelumab 2X-Rays 2Ritonavir 2Radiotherapy 2Observation 2Methods 2Immunoglobulin G 2IFL protocol 2Drug Therapy 2zimberelimab 1utomilumab 1ulixertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Cognitive Behavioral Therapy × Dermatologic × Clear all
NCT03112668 2021-04-08

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

Rutgers, The State University of New Jersey

Phase NA Completed
14 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡